Home › Funds › Farallon Capital Management › CGON
Farallon Capital Management position in CGON
CG ONCOLOGY INC · Health Care
Latest position (Q2 2026)400.00K sh
Reported value held$28.42M
Portfolio Weight0.13%
First reportedQ2 2025
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2025 | 8.00K | $208.00K | New |
| Q3 2025 | 8.00K | $322.24K | Hold |
| Q4 2025 | 8.00K | $332.16K | Hold |
| Q1 2026 | 200.00K | $13.54M | Add |
| Q2 2026 | 400.00K | $28.42M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding CGON
- BlackRock Inc 6.26M sh · $444.51M · Q2 2026
- Wellington Management Group 5.32M sh · $378.32M · Q2 2026
- Fidelity Management & Research (FMR) 4.16M sh · $295.67M · Q2 2026
- Vanguard Group 6.54M sh · $271.52M · Q4 2025
- Geode Capital Management 2.15M sh · $153.02M · Q2 2026
- Franklin Resources 1.31M sh · $93.28M · Q2 2026
- Morgan Stanley 1.18M sh · $83.63M · Q2 2026
- Bank of America Corp 984.92K sh · $69.98M · Q2 2026
- UBS Group AG 977.70K sh · $69.47M · Q2 2026
- Goldman Sachs Group 857.71K sh · $60.94M · Q2 2026
- Northern Trust Corp 677.91K sh · $48.17M · Q2 2026
- Charles Schwab Investment Management 627.18K sh · $44.56M · Q2 2026